The SORT OUT IX STEMI OCT Trial (OCT STEMI SOIX)
Primary Purpose
Acute Myocardial Infarction
Status
Unknown status
Phase
Not Applicable
Locations
Denmark
Study Type
Interventional
Intervention
BioFreedom
Orsiro
Sponsored by
About this trial
This is an interventional treatment trial for Acute Myocardial Infarction focused on measuring drug eluting stents, coronary vascular healing
Eligibility Criteria
Inclusion Criteria:
- Patients aged 18 years or over with STEMI, requiring treatment with a drug-eluting stent.
Exclusion Criteria:
- life expectancy of less than one year; an allergy to aspirin, clopidogrel, ticagrelor, prasugral, biolimus or sirolimus; participation in another randomized trial; chronic renal disease; or inability to provide written informed consent.
Sites / Locations
- Aarhus University Hospital
- Copenhagen University Hospital
- Odense University Hospital
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Biofreedom
Orsiro
Arm Description
Experimental: Biofreedom BioFreedom stent at index procedure
Active comparator: Orsiro Orsiro stent at index procedure
Outcomes
Primary Outcome Measures
Vascular healing index (uncovered stent struts, malapposed stent struts, maximal intima coverage and accumulated extra-stent lumen volume) assessed with optical coherence tomography (OCT) 1 month after primary PCI.
Secondary Outcome Measures
Target lesion failure
Full Information
NCT ID
NCT02915107
First Posted
September 22, 2016
Last Updated
September 17, 2020
Sponsor
Odense University Hospital
Collaborators
Aarhus University Hospital, Rigshospitalet, Denmark
1. Study Identification
Unique Protocol Identification Number
NCT02915107
Brief Title
The SORT OUT IX STEMI OCT Trial
Acronym
OCT STEMI SOIX
Official Title
Randomized Comparison of Vascular Healing of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients With ST-segment Elevation Myocardial Infarction
Study Type
Interventional
2. Study Status
Record Verification Date
September 2020
Overall Recruitment Status
Unknown status
Study Start Date
September 2016 (undefined)
Primary Completion Date
September 2018 (Actual)
Study Completion Date
September 2023 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Odense University Hospital
Collaborators
Aarhus University Hospital, Rigshospitalet, Denmark
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim of the Danish Organization for Randomized Trials with Clinical Outcome (SORT OUT) IX STEMI OCT is to compare early vascular healing of the polymer-free Biolimus-eluting BIOFREEDOM stent with a biodegradable-polymer Sirolimus-eluting ORSIRO stent in patients with ST-segment elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI).
Detailed Description
SORT OUT IX STEMI OCT is a randomized 1:1 study comparing the polymer-free Biolimus-eluting BIOFREEDOM stent with a biodegradable-polymer Sirolimus-eluting ORSIRO stent patients with STEMI treated with primary PCI.
Vascular healing index (uncovered stent struts, malapposed stent struts, maximal intima coverage and accumulated extra-stent lumen volume) assessed with optical coherence tomography (OCT) 1 month after primary PCI.
Patients will be enrolled by the investigators and randomly allocated to treatment groups after diagnostic coronary angiography and before primary PCI. A web based Trial Partner randomization system will be used.
OCT will be performed with the frequency-domain OPTIS OCT system and Dragonfly™ Imaging Catheter during the index procedure and after 1 months.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction
Keywords
drug eluting stents, coronary vascular healing
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
80 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Biofreedom
Arm Type
Experimental
Arm Description
Experimental: Biofreedom BioFreedom stent at index procedure
Arm Title
Orsiro
Arm Type
Active Comparator
Arm Description
Active comparator: Orsiro Orsiro stent at index procedure
Intervention Type
Device
Intervention Name(s)
BioFreedom
Intervention Description
PCI with BioFreedom
Intervention Type
Device
Intervention Name(s)
Orsiro
Intervention Description
PCI with BioFreedom
Primary Outcome Measure Information:
Title
Vascular healing index (uncovered stent struts, malapposed stent struts, maximal intima coverage and accumulated extra-stent lumen volume) assessed with optical coherence tomography (OCT) 1 month after primary PCI.
Time Frame
Primary endpoint assessed after 1 month
Secondary Outcome Measure Information:
Title
Target lesion failure
Time Frame
1 year, 2 years, 3 years, 4 years, 5 years
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients aged 18 years or over with STEMI, requiring treatment with a drug-eluting stent.
Exclusion Criteria:
life expectancy of less than one year; an allergy to aspirin, clopidogrel, ticagrelor, prasugral, biolimus or sirolimus; participation in another randomized trial; chronic renal disease; or inability to provide written informed consent.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Lisette Okkels Jensen, MD DMSci PhD
Organizational Affiliation
Odense University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Aarhus University Hospital
City
Aarhus
ZIP/Postal Code
8210
Country
Denmark
Facility Name
Copenhagen University Hospital
City
Copenhagen
Country
Denmark
Facility Name
Odense University Hospital
City
Odense
ZIP/Postal Code
5000
Country
Denmark
12. IPD Sharing Statement
Citations:
PubMed Identifier
34985003
Citation
Hansen KN, Maeng M, Antonsen L, Maehara A, Jakobsen L, Ellert J, Terkelsen CJ, Ahlehoff O, Thim T, Fallesen CO, Noori M, Veien KT, Jensen LO, Christiansen EH. Early vascular healing after implantation of the polymer-free biolimus-eluting stent or the ultrathin strut biodegradable polymer sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction. Coron Artery Dis. 2022 May 1;33(3):196-205. doi: 10.1097/MCA.0000000000001113.
Results Reference
derived
Learn more about this trial
The SORT OUT IX STEMI OCT Trial
We'll reach out to this number within 24 hrs